What a cracking announcement - also puts into perspective how important that $38.5m funding facility is.
No struggling for funding with a small trial size of 60 - straight to a 156 possible participants and the chance that the significance of that data really fast tracks the development of this inhaled therapy.
Someone had a little nibble at 3.3c yesterday and I cant help thinking if the news flow keeps coming in positive like this there wont be much left to buy soon if the company can promote this buying opportunity.
Top 20 hold over 75% of this company and appear to be longer term holders so doesn't leave much free float for the rest!
Cheers,
Disco.
Add to My Watchlist
What is My Watchlist?
